Baltimore Councilman James Torrence, a Democrat, took Spotlight on Maryland on a tour of revitalization efforts hours after police cars left on Thursday at the open-air drug market inside his legislative district at Woodbrook and North Fulton. Spotlight on Maryland’s interaction with the man on Thursday marked the six-week anniversary of a mass drug overdose event that happened in the same Penn North open-air drug market. The incident resulted in at least 27 people being hospitalized, with some in critical condition. The immunology segment is expected to register the fastest CAGR of 8.1% from 2025 to 2032, owing to increasing cases of autoimmune disorders and advancements in biologics. Unlock industry potential through cutting-edge research, data-driven insights, and strategic guidance. A curation of IQVIA’s best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
Which Are The Driving Factors Of The Pharmaceutical Market?
Companies prioritize research and development to address unmet medical needs and comply with evolving regulatory standards. Investments in biologics, RNAi-based therapeutics, and specialty drugs are key strategies driving growth and improving treatment accessibility across various disease segments. The branded segment dominated the pharmaceutical market with a revenue share of 86.76% in 2024. The branded segment is a basis of the pharmaceutical market, fueling growth through innovation and exclusivity. These are patented medicines marketed under proprietary names, addressing critical healthcare challenges such as chronic diseases, cancer, and rare disorders. Their premium pricing reflects the substantial investment in research, development, and regulatory approvals and the value they deliver in advancing treatment standards.
Get A Free Sample Of This Report
Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope. By route of administration, the oral segment secured the largest share of the market in 2023. The most popular method of medication delivery is oral since it is non-invasive, highly patient-complied with, economical, easy to use, and doesn’t require any special sterile conditions.
Global Market Dynamics: Size, Scope, And Trajectory
This situation can impact profit margins and hinder the ability of manufacturers to stand out in a crowded market. The generic drugs market is subject to stringent regulatory requirements to ensure the safety, quality, and effectiveness of generic medications. Funding assists generic drug manufacturers in meeting these regulatory compliance standards, such as conducting clinical trials, obtaining necessary certifications, and meeting manufacturing facility requirements. Adequate funding enables manufacturers to navigate the regulatory landscape and gain necessary approvals for their generic products. In addition, funding plays a crucial role in establishing and expanding the manufacturing infrastructure for generic drugs. This includes investments in state-of-the-art facilities, equipment, and technologies that meet Good Manufacturing Practices (GMP) standards.
The U.S. FDA particularly approved these generic equivalents to improve drug competition and to also encourage the increasing adoption of these low-cost drug equivalents. This is especially critical for patients in emerging markets and also patients in developed countries who do not have access to appropriate payment plans for prescription medicines. By distribution channel, the retail pharmacies segment dominated the market in 2024 by holding the major revenue share of the market. Nowadays, customers are looking for more convenient approaches to access drugs, in which retail pharmacies are playing a major role. As they provide reasonable and easy availability of generic drugs is also propelling the growth of the drugs market. Also, they are offering a broad range of consumer-centric services like home healthcare, laboratory services, and specialty pharmacy services, to meet the developing needs of customers.
The pharmaceutical market in the U.S. is the largest in North America, supported by strong government policies, high consumer spending, and extensive biopharma investments. Growth is fueled by rising demand for biologics, oncology drugs, and rare disease therapies. Increasing FDA approvals and the expanding pipeline of specialty treatments further accelerate market growth. Hospital pharmacies remain the dominant distribution channel, with retail pharmacies enhancing access to chronic disease treatments.
The oral segment accounted for the largest revenue share of 51.2% in 2024, due to ease of use and widespread application in chronic disease management. On the basis of type, the prescription drugs market is segmented into branded and generic. The branded drugs segment dominated the market with the largest revenue share of 62.5% in 2024, attributed to patent exclusivity, strong marketing strategies, and clinical preference in specialty therapeutics. The growing chronic diseases among the elderly population contribute to the segment’s growth.
Pharmaceutical Market Size To Hit USD 303 Trillion By 2034
It also reflects how effectively these organizations can shift their production and distribution systems in response to these enforcement shifts. If sellers can shift sales activities indoors or otherwise avoid the increased enforcement, the shift from S1 to S2 will be small. Despite these limitations, the basic supply-and-demand model provides a specific language to explore causal pathways of proposed public policies.
This is largely due to the increasing incidence of cancer, advancements in personalized medicine, and the development of targeted therapies. Collaborations between pharmaceutical companies and research institutions are accelerating the development of innovative oncology treatments, further driving the growth of this segment. The pharmaceutical market is divided into biologics & biosimilars (large molecules) and conventional drugs (small molecules). Their widespread adoption is due to their well-established manufacturing processes, predictable pharmacokinetics, and oral bioavailability. Small molecules are widely used in various therapeutic applications, and their patent expirations allow for the entry of generics, further driving market growth.
Competition Among Small Molecule Drugs And Biological
In response to the pandemic, major pharmacy chains like Walmart, Walgreens Boots Alliance, CVS Health and Rite Aid have reported a sharp increase in demand for flu shots in their U.S. pharmacies in 2020, in some cases double from the previous year. The rest of the world market comprises Latin America and the Middle East & Africa and is currently in a stage of growth. Increasing use of advanced prescription products and increasing healthcare expenditure are projected to fuel the market growth during the forecast period. In terms of therapy, the market is segmented into oncology, central nervous system, vaccines, immunosuppressants, and others. The oncology segment is anticipated to dominate the therapy segment due to the increasing prevalence of cancer and the high costs attributed to the treatment of the various forms of cancer. Further, the rising number of regulatory approvals for targeted therapies in the treatment of cancer is another factor contributing to the segmental growth.
Prior to the founding of eBay and related websites, search costs and quality differences were dominant factors in the markets for collectibles and antiques. Intervention was launched about the same time as a nonprice influence shifted the demand curve out (up and to the right). An example of such a demand influence is an increase in the population cohort size of adolescents and young adults.
Catheters Market Growth Driven By AI And Innovation
Rising R&D initiatives by key players for the development of specialty drugs across serious indications further augment the growth of the market. Prescription drugs can be defined as pharmaceutical drugs dispensed through a medical prescription by a healthcare professional. These drugs are prescribed for several therapeutic indications, such as cancer, cardiovascular diseases, and diabetes, among others, across the globe. The launch of these drugs is regulated through regulatory agencies such as the Food and Drug Administration (FDA) through the New Drug Application (NDA) process for marketing across the globe.
Rohan Patil is a seasoned market research professional with over 5+ years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes. DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. We empower life sciences with connected intelligence, transforming data into actionable insights for smarter decisions and better patient outcomes. Enhance your ability to evaluate and forecast population risk swiftly and accurately by integrating unmatched data, expertise, and technology. Overall, the proper prescription and utilization of these medications remain critical in promoting better health outcomes and well-being for individuals worldwide.
- In 2024, Merck’s Keytruda continued its reign with nearly $29.5 billion in sales, posting solid 17.9% growth over 2023.
- For example, the intensity of a drug experience is influenced by the time since last use, the expectations of the user, and circumstances of use, summarized in the phrase, “drug, set, and setting” (Zinberg, 1984).
- By route of administration, the parenteral segment is estimated to grow at the fastest rate in the pharmaceutical market in 2023.
- In addition, the report offers insights into the market trends and highlights key industry developments.
- The rise in sedentary jobs, busy lifestyles, and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes, and cardiovascular diseases.
- The basic supply-and-demand approach from economics provides a useful analytical framework to understand markets for illegal drugs.
KEY FINDINGS
By distribution channel, the hospital pharmacies segment is anticipated to show lucrative growth in the market over the coming years. The segmental growth is attributed to the presence of trained professionals and the increasing number of hospitalizations. Hospital pharmacies contain all the medicines that are prescribed by healthcare professionals. This platform contains insights related to the latest global, regional and subregional estimates and trends in drug demand and drug supply in the form of global, regional and sub-regional Key Findings that are easy to search.
The Canada Drugs Market Trends
In addition, cost-effectiveness and convenience, along with growing awareness through digital platforms, enhanced consumer adoption, positioning the OTC segment as a key growth driver in the market. The generic segment is expected to register the fastest growth rate over the projected period, driven by a high number of patent expiries in 2024, increasing demand for affordable medications, and rising healthcare expenditure. Supportive regulatory frameworks and cost-containment measures by governments and healthcare providers are further encouraging the adoption of generics. The segment’s growth is also bolstered by improved manufacturing capabilities, enhanced distribution networks, and growing awareness among patients and healthcare professionals regarding the effectiveness of generic alternatives. Key factors that are driving the market growth include increasing chronic disease prevalence, rising geriatric population, increasing healthcare spending by government organizations globally, and extensive efforts to improve the affordability of pharmaceuticals. Despite the strong growth drivers, the generic drug market is fraught with significant challenges that test the resilience and strategic acumen of even the most established players.
